The results revealed that COPZ2 expression was significantly upregulated in GBM (glioblastoma IV grade), HNSC (Head and Neck squamous cell carcinoma), KIRC (Kidney renal clear cell carcinoma), LUSC (Lung squamous cell carcinoma). This evidence concerns the gene COPZ2 and head and neck squamous cell carcinoma.